Surgery and ablation are comparable for the treatment of solitary hepatocellular carcinoma (HCC) that is no larger than 3 cm in diameter, according to results published in the Journal of Liver Cancer. Researchers compared the...
Cyclin-dependent kinase regulatory subunit 2 (CKS2) may represent a prognostic biomarker of hepatocellular carcinoma (HCC) through its ability to promote disease progression via its impact on the immune microenvironment,...